NHS Framework Agreement for the Supply of Human Normal Immunoglobulin & Anti-D Immunoglobulin
Awarded by NHS ENGLAND · 2021-09-14T12:55:09+01:00 · £300,000,000
Description
Human Normal Immunoglobulin & Anti-D Immunoglobulin Period of framework agreement: 1 January 2023 to 31 December 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months
- Buyer
- NHS ENGLAND
- Value
- £300,000,000
- Category (CPV)
- Immunoglobulins
- Award date
- 2021-09-14T12:55:09+01:00
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.